What Analysts Think Is Changing the Story for Mirum Pharmaceuticals Now [Yahoo! Finance]
Mirum Pharmaceuticals, Inc. - common stock (MIRM)
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
revenue growth expectations from 21.67% to 21.02%. A slightly lower discount rate of 7.15% versus 7.20% signals that markets see marginally less risk in the story, anchored by steady Livmarli performance and rising anticipation for volixibat data. Stay tuned to see how you can track these evolving assumptions and the shifting narrative around Mirum in real time. Stay updated as the Fair Value for Mirum Pharmaceuticals shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Mirum Pharmaceuticals. ?? Bullish Takeaways Citizens JMP lifted its Mirum Pharmaceuticals price target to $95 from $81 while reiterating an Outperform rating, citing another strong quarter for Livmarli and calling Mirum one of its favorite smid cap biotech names with the stock up roughly 70% year to date. Analysts at both Citizens JMP and Morgan Stanley see Livmarli's commercial execution and Mirum's path to profitability as central to the equ
Show less
Read more
Impact Snapshot
Event Time:
MIRM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MIRM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MIRM alerts
High impacting Mirum Pharmaceuticals, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
MIRM
News
- Mirum Pharmaceuticals: Rich In 2025, Richer (In Promise) In 2026? I Believe So [Seeking Alpha]Seeking Alpha
- Mirum: Maintaining Buy Rating On VOLIXIBAT PSC Treatment Data Q2 2026 [Seeking Alpha]Seeking Alpha
- Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX [Yahoo! Finance]Yahoo! Finance
- Mirum Pharmaceuticals (NASDAQ:MIRM) had its price target raised by analysts at Citizens Jmp from $95.00 to $140.00. They now have a "market outperform" rating on the stock.MarketBeat
- Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGXBusiness Wire
MIRM
Earnings
- 11/4/25 - Beat
MIRM
Sec Filings
- 12/23/25 - Form 4
- 12/23/25 - Form 4
- 12/22/25 - Form 144
- MIRM's page on the SEC website